Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2

키워드

참고문헌 (35)

1. Zhou P, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", Nature, 579, pp.270~273 (2020)
2. Cucinotta D, "WHO Declares COVID-19 a Pandemic", Acta Biomed, 91, pp.157~160 (2020)
3. Nicola M, "The socio-economic Implications of the Coronavirus and COVID-19 Pandemic : a review", Int. J. Surg, 78, pp.185~193 (2020)
4. Lake MA, "What we know so far : COVID-19 current clinical knowledge and research", Clin. Med. (Lond), 20, pp.124~127 (2020)
5. Guan WJ, "Clinical characteristics of Coronavirus Disease 2019 in China", N. Engl. J. Med, 382, pp.1708~1720 (2020)
6. Weiss P, "Clinical course and mortality risk of severe COVID-19", Lancet, 395, pp.1014~1015 (2020)
7. 이정윤, "Middle East Respiratory Syndrome Coronavirus-Encoded Accessory Proteins Impair MDA5-and TBK1-Mediated Activation of NF-κB", Journal of Microbiology and Biotechnology, 29(8), pp.1316~1323 (2019), 한국미생물·생명공학회[DOI]
8. 이정윤, "Middle East Respiratory Syndrome Coronavirus-Encoded ORF8b Inhibits RIG-I-Like Receptors by a Differential Mechanism", Journal of Microbiology and Biotechnology, 29(12), pp.2014~2021 (2019), 한국미생물·생명공학회[DOI]
9. 이정윤, "Generation of Full-Length Infectious cDNA Clones of Middle East Respiratory Syndrome Coronavirus", Journal of Microbiology and Biotechnology, 29(6), pp.999~1007 (2019), 한국미생물·생명공학회[DOI]
10. Ashburn TT, "Drug repositioning : identifying and developing new uses for existing drugs", Nat. Rev. Drug Discov, 3, pp.673~683 (2004)
11. Cao B, "A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19", N. Engl. J. Med, 382, pp.1787~1799 (2020)
12. Grein J, "Compassionate use of remdesivir for patients with severe Covid-19", N. Engl. J. Med, 382, pp.2327~2336 (2020)
13. Kim HS, "Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection", Genome Res, 28, pp.859~868 (2018)
14. Wang M, "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus(2019-nCoV)in vitro", Cell Res, 30, pp.269~271 (2020)
15. Weber F, "Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses", J. Virol, 80, pp.5059~5064 (2006)
16. Amery WK, "Flunarizine, a calcium channel blocker : a new prophylactic drug in migraine", Headache, 23, pp.70~74 (1983)
17. Ishii M, "Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery", J. Pharmacol. Sci, 111, pp.221~225 (2009)
18. Wang S, "Screening of FDA-Approved drugs for Inhibitors of Japanese Encephalitis Virus infection", J. Virol, 91, pp.e01055~ (2017)
19. Perin PM, "Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1", Hepatology, 63, pp.49~62 (2016)
20. Johansen LM, "A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity", Sci. Transl. Med, 7, pp.290ra289~ (2015)
21. Nathan L, "Calcium ions directly interact with the Ebola virus fusion peptide to promote structure-function changes that enhance infection", ACS Infect. Dis, 6, pp.250~260 (2020)
22. Wibble T, "The effects of meclizine on motion sickness revisited", Br. J. Clin. Pharmacol, 86, pp.1510~1518 (2020)
23. Guo J, "Meclizine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis partially by upregulating PXR", Front. Pharmacol, 8, pp.693~ (2017)
24. Mostafa GA, "Buclizine", Profiles Drug Subst. Excip. Relat. Methodol, 36, pp.1~33 (2011)
25. D’Alessandro S, "The use of antimalarial drugs against viral infection", Microorganisms, 8, pp.85~ (2020)
26. Han Y, "The antimalarial drug amodiaquine possesses anti-ZIKA virus activities", J. Med. Virol, 90, pp.796~802 (2018)
27. Dyall J, "Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection", Antimicrob. Agents Chemother, 58, pp.4885~4893 (2014)
28. Pappas PG, "Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis", Clin. Infect. Dis, 45, pp.883~893 (2007)
29. Denning DW, "Echinocandin antifungal drugs", Lancet, 362, pp.1142~1151 (2003)
30. Kim C, "Antiviral activity of micafungin against enterovirus 71", Virol. J, 13, pp.99~ (2016)
31. Ho YJ, "Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms", Antiviral. Res, 159, pp.134~142 (2018)
32. Ansarin K, "Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients : A randomized clinical trial", Bioimpacts, 10, pp.209~215 (2020)
33. Antoszczak M, "Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides", Molecules, 19, pp.19435~19459 (2014)
34. Ianevski A, "Potential antiviral options against SARS-CoV-2 infection", Viruses, 12, pp.642~ (2020)
35. Vogel JU, "The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation", Cells, 9, pp.31~ (2019)

관련 논문AI추천